Literature DB >> 14889782

Nisin in experimental tuberculosis.

E M BAVIN, A S BEACH, R FALCONER, R FRIEDMANN.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1952        PMID： 14889782     DOI： 10.1016/s0140-6736(52)92429-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Observations on the molecular weight and chemical composition of nisin A.

Authors:  G C CHEESEMAN; N J BERRIDGE
Journal:  Biochem J       Date:  1959-01       Impact factor: 3.857

2.  Purification and nature of the antibiotic nisin.

Authors:  N J BERRIDGE; G G F NEWTON; E P ABRAHAM
Journal:  Biochem J       Date:  1952-12       Impact factor: 3.857

Review 3.  New horizons for host defense peptides and lantibiotics.

Authors:  Michael John Dawson; Richard W Scott
Journal:  Curr Opin Pharmacol       Date:  2012-07-07       Impact factor: 5.547

4.  Some properties of nisin.

Authors:  J L GOWANS; N SMITH; H W FLOREY
Journal:  Br J Pharmacol Chemother       Date:  1952-09

Review 5.  Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.

Authors:  Leif Smith; Jd Hillman
Journal:  Curr Opin Microbiol       Date:  2008-10-24       Impact factor: 7.934

6.  Easy and rapid purification of highly active nisin.

Authors:  André Abts; Antonino Mavaro; Jan Stindt; Patrick J Bakkes; Sabine Metzger; Arnold J M Driessen; Sander H J Smits; Lutz Schmitt
Journal:  Int J Pept       Date:  2011-09-18

7.  Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.

Authors:  Des Field; Lisa Quigley; Paula M O'Connor; Mary C Rea; Karen Daly; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Microb Biotechnol       Date:  2010-07       Impact factor: 5.813

8.  First evidence of production of the lantibiotic nisin P.

Authors:  Enriqueta Garcia-Gutierrez; Paula M O'Connor; Gerhard Saalbach; Calum J Walsh; James W Hegarty; Caitriona M Guinane; Melinda J Mayer; Arjan Narbad; Paul D Cotter
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.